Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants

Neuroscientist

Volumn 22, Issue 1, 2016, Pages 26-45

  Samuels, Benjamin Adam ^a   Mendez David, Indira ^b   Faye, Charlène ^b   David, Sylvain André ^c   Pierz, Kerri A ^c   Gardier, Alain M ^b   Hen, René ^a   David, Denis J ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c NONE

Author keywords

5 HT1A receptor; 5 HT4 receptor; anxiety; major depressive disorders; mood disorders; neurogenesis

Indexed keywords

SEROTONIN 1A RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; ANIMAL; DRUG EFFECTS; METABOLISM; MOOD DISORDERS; PHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; HIPPOCAMPUS; HUMANS; MOOD DISORDERS; NEUROGENESIS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, SEROTONIN, 5-HT4;

EID: 84954216052     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858414561303     Document Type: Review

References (135)

1. Albert PR, Lembo P, Storring JM, Charest A, Saucier C,. 1996. The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 14 (1): 19-25.
2. Banasr M, Hery M, Printemps R, Daszuta A,. 2004. Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 29 (3): 450-60.
3. Barnes NM, Sharp T,. 1999. A review of central 5-HT receptors and their function. Neuropharmacology 38 (8): 1083-152.
4. Barrett JE, Vanover KE,. 1993. 5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions. Psychopharmacology (Berl) 112 (1): 1-12.
5. Barthet G, Gaven F, Framery B, Shinjo K, Nakamura T, Claeysen S, and others. 2005. Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements. J Biol Chem 280 (30): 27924-34.
6. Blier P,. 2003. The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol 13 (2): 57-66.
7. Blier P, de Montigny C,. 1987. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1 (5): 470-80.
8. Blier P, de Montigny C, Chaput Y,. 1990. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry 51 (Suppl): 14-20.
9. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C,. 1998. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 861: 204-16.
10. Bockaert J, Claeysen S, Compan V, Dumuis A,. 2004. 5-HT4 receptors. Curr Drug Targets CNS Neurol Disord 3 (1): 39-51.
11. Bockaert J, Claeysen S, Compan V, Dumuis A,. 2008. 5-HT(4) receptors: history, molecular pharmacology and brain functions. Neuropharmacology 55 (6): 922-31.
12. Bockaert J, Sebben M, Dumuis A,. 1990. Pharmacological characterization of 5-hydroxytryptamine 4 (5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. Mol Pharmacol 37 (3): 408-11.
13. Bohn LM, Schmid CL,. 2010. Serotonin receptor signaling and regulation via beta-arrestins. Crit Rev Biochem Mol Biol 45 (6): 555-66.
14. Boldrini M, Underwood MD, Mann JJ, Arango V,. 2008. Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 42 (6): 433-42.
15. Burghardt NS, Bauer EP,. 2013. Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits. Neuroscience 247: 253-72.
16. Cai X, Flores-Hernandez J, Feng J, Yan Z,. 2002. Activity-dependent bidirectional regulation of GABA(A) receptor channels by the 5-HT(4) receptor-mediated signalling in rat prefrontal cortical pyramidal neurons. J Physiol 540 (Pt 3): 743-59.
17. Castren E,. 2014. Neurotrophins and psychiatric disorders. Handb Exp Pharmacol 220: 461-79.
18. Chen A, Kelley LD, Janusonis S,. 2012. Effects of prenatal stress and monoaminergic perturbations on the expression of serotonin 5-HT(4) and adrenergic β2 receptors in the embryonic mouse telencephalon. Brain Res 1459: 27-34.
19. Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A,. 1999. Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 55 (5): 910-20.
20. Claeysen S, Sebben M, Journot L, Bockaert J, Dumuis A,. 1996. Cloning, expression and pharmacology of the mouse 5-HT(4L) receptor. FEBS Lett 398 (1): 19-25.
21. Compan V, Daszuta A, Salin P, Sebben M, Bockaert J, Dumuis A,. 1996. Lesion study of the distribution of serotonin 5-HT4 receptors in rat basal ganglia and hippocampus. Eur J Neurosci 8 (12): 2591-8.
22. Compan V, Zhou M, Grailhe R, Gazzara RA, Martin R, Gingrich J, and others. 2004. Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice. J Neurosci 24 (2): 412-9.
23. Costall B, Naylor RJ,. 1997. The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test. Br J Pharmacol 122 (6): 1105-18.
24. Costall B, Naylor RJ, Tuladhar BR,. 1993. 5-HT4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum. Br J Pharmacol 110 (4): 1572-8.
25. Cryan JF, Lucki I,. 2000. 5-HT4 receptors do not mediate the antidepressant-like behavioral effects of fluoxetine in a modified forced swim test. Eur J Pharmacol 409 (3): 295-9.
26. Czachura JF, Rasmussen K,. 2000. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharmacol 362 (3): 266-75.
27. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, and others. 2009. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62 (4): 479-93.
28. Descarries L, Riad M,. 2012. Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT. Philos Trans R Soc Lond B Biol Sci 367 (1601): 2416-25.
29. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, and others. 2007. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34 (7): 865-77.
30. Duman RS, Malberg J, Nakagawa S,. 2001. Regulation of adult neurogenesis by psychotropic drugs and stress. J Pharmacol Exp Ther 299 (2): 401-7.
31. Duman RS, Malberg J, Nakagawa S, D'Sa C,. 2000. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48 (8): 732-9.
32. Duman RS, Monteggia LM,. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59 (12): 1116-27.
33. Dumuis A, Bouhelal R, Sebben M, Bockaert J,. 1988. A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205 930. Eur J Pharmacol 146 (1): 187-8.
34. Dumuis A, Sebben M, Bockaert J,. 1989. BRL 24924: a potent agonist at a non-classical 5-HT receptor positively coupled with adenylate cyclase in colliculi neurons. Eur J Pharmacol 162 (2): 381-4.
35. Egeland M, Warner-Schmidt J, Greengard P, Svenningsson P,. 2011. Co-expression of serotonin 5-HT(1B) and 5-HT(4) receptors in p11 containing cells in cerebral cortex, hippocampus, caudate-putamen and cerebellum. Neuropharmacology 61 (3): 442-50.
36. Eglen RM, Cornett CM, Whiting RL,. 1990. Interaction of p-F-HHSiD (p -fluoro-hexahydrosila-difenidol) at muscarinic receptors in guinea-pig trachea. Naunyn Schmiedebergs Arch Pharmacol 342 (4): 394-9.
37. Eglen RM, Wong EH, Dumuis A, Bockaert J,. 1995. Central 5-HT4 receptors. Trends Pharmacol Sci 16 (11): 391-8.
38. Fakra E, Hyde LW, Gorka A, Fisher PM, Munoz KE, Kimak M, and others. 2009. Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry 66 (1): 33-40.
39. Fargin A, Raymond JR, Lohse MJ, Kobilka BK, Caron MG, Lefkowitz RJ,. 1988. The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335 (6188): 358-60.
40. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, and others. 2013. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 10 (11): e1001547.
41. Gaddum JH, Picarelli ZP,. 1957. Two kinds of tryptamine receptor. Br J Pharmacol 12 (3): 323-8.
42. Garcia-Garcia AL, Newman-Tancredi A, Leonardo ED,. 2014. 5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology (Berl) 231 (4): 623-36.
43. Gardier AM, Malagie I, Trillat AC, Jacquot C, Artigas F,. 1996. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10 (1): 16-27.
44. Gerald C, Adham N, Kao HT, Olsen MA, Laz TM, Schechter LE, and others. 1995. The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J 14 (12): 2806-15.
45. Gomez-Lazaro E, Garmendia L, Beitia G, Perez-Tejada J, Azpiroz A, Arregi A,. 2012. Effects of a putative antidepressant with a rapid onset of action in defeated mice with different coping strategies. Prog Neuropsychopharmacol Biol Psychiatry 38 (2): 317-27.
46. Grabiec M, Turlejski K, Djavadian RL,. 2009. The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica). Eur Neuropsychopharmacol 19 (6): 431-9.
47. Griebel G,. 1995. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 65 (3): 319-95.
48. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, and others. 2002. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 (6879): 396-400.
49. Grossman CJ, Kilpatrick GJ, Bunce KT,. 1993. Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol 109 (3): 618-24.
50. Guilloux JP, David DJ, Guiard BP, Chenu F, Reperant C, Toth M, and others. 2006. Blockade of 5-HT1A receptors by (±)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology 31 (10): 2162-72.
51. Hannon J, Hoyer D,. 2008. Molecular biology of 5-HT receptors. Behav Brain Res 195 (1): 198-213.
52. Hegde SS, Eglen RM,. 1996. Peripheral 5-HT4 receptors. FASEB J 10 (12): 1398-407.
53. Heisler LK, Chu HM, Brennan TJ, Danao JA, Bajwa P, Parsons LH, and others. 1998. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci U S A 95 (25): 15049-54.
54. Holick KA, Lee DC, Hen R, Dulawa SC,. 2008. Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33 (2): 406-17.
55. Ishizuka T, Goshima H, Ozawa A, Watanabe Y,. 2014. Stimulation of 5-HT4 receptor enhances differentiation of mouse induced pluripotent stem cells into neural progenitor cells. Clin Exp Pharmacol Physiol 41 (5): 345-50.
56. Jacobs BL, van Praag H, Gage FH,. 2000. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5 (3): 262-9.
57. Jean A, Laurent L, Bockaert J, Charnay Y, Dusticier N, Nieoullon A, and others. 2012. The nucleus accumbens 5-HTR(4)-CART pathway ties anorexia to hyperactivity. Transl Psychiatry 2: e203.
58. Kaufman J, Charney D,. 2000. Comorbidity of mood and anxiety disorders. Depress Anxiety 12 (Suppl 1): 69-76.
59. Kennett GA, Bright F, Trail B, Blackburn TP, Sanger GJ,. 1997. Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats. Neuropharmacology 36 (4-5): 707-12.
60. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE,. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 (6): 617-27.
61. King MV, Marsden CA, Fone KC,. 2008. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29 (9): 482-92.
62. Klemenhagen KC, Gordon JA, David DJ, Hen R, Gross CT,. 2006. Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology 31 (1): 101-11.
63. Klempin F, Babu H, De Pietri Tonelli D, Alarcon E, Fabel K, Kempermann G,. 2010. Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis. Front Mol Neurosci 3:Article 14.
64. Kobayashi K, Ikeda Y, Sakai A, Yamasaki N, Haneda E, Miyakawa T, and others. 2010. Reversal of hippocampal neuronal maturation by serotonergic antidepressants. Proc Natl Acad Sci U S A 107 (18): 8434-9.
65. Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, and others. 1987. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329 (6134): 75-9.
66. Kreiss DS, Lucki I,. 1997. Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Synapse 25 (2): 107-16.
67. Le Francois B, Czesak M, Steubl D, Albert PR,. 2008. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 55 (6): 977-85.
68. Le Poul E, Laaris N, Doucet E, Laporte AM, Hamon M, Lanfumey L,. 1995. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol 352 (2): 141-8.
69. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, and others. 2003. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23 (25): 8788-99.
70. Lesch KP, Gutknecht L,. 2004. Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int J Neuropsychopharmacol 7 (4): 381-5.
71. Li Q, Muma NA, van de, Kar LD,. 1996. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279 (2): 1035-42.
72. Licht CL, Kirkegaard L, Zueger M, Chourbaji S, Gass P, Aznar S, and others. 2010. Changes in 5-HT4 receptor and 5-HT transporter binding in olfactory bulbectomized and glucocorticoid receptor heterozygous mice. Neurochem Int 56 (4): 603-10.
73. Licht CL, Marcussen AB, Wegener G, Overstreet DH, Aznar S, Knudsen GM,. 2009. The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. J Neurochem 109 (5): 1363-74.
74. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD,. 2009. 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29 (31): 9683-99.
75. Lucas G,. 2009. Serotonin receptors, type 4: a new hope? Curr Drug Targets 10 (11): 1085-95.
76. Lucas G, Compan V, Charnay Y, Neve RL, Nestler EJ, Bockaert J, and others. 2005. Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: viral transfections, subacute and chronic treatments with 5-HT4 agonists. Biol Psychiatry 57 (8): 918-25.
77. Lucas G, Rymar VV, Du J, Mnie-Filali O, Bisgaard C, Manta S, and others. 2007. Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55 (5): 712-25.
78. Lucki I,. 1991. Behavioral studies of serotonin receptor agonists as antidepressant drugs. J Clin Psychiatry 52 (Suppl): 24-31.
79. Macdonald RL, Olsen RW,. 1994. GABAA receptor channels. Annu Rev Neurosci 17: 569-602.
80. Malberg JE, Eisch AJ, Nestler EJ, Duman RS,. 2000. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (24): 9104-10.
81. Mannoury la, Cour C, El Mestikawy S, Hanoun N, Hamon M, Lanfumey L,. 2006. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol Pharmacol 70 (3): 1013-21.
82. Marin P, Becamel C, Dumuis A, Bockaert J,. 2012. 5-HT receptor-associated protein networks: new targets for drug discovery in psychiatric disorders? Curr Drug Targets 13 (1): 28-52.
83. Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I,. 2001. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 298 (3): 1101-7.
84. McAskill R, Mir S, Taylor D,. 1998. Pindolol augmentation of antidepressant therapy. Br J Psychiatry 173: 203-8.
85. Meltzer CC, Price JC, Mathis CA, Butters MA, Ziolko SK, Moses-Kolko E, and others. 2004. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29 (12): 2258-65.
86. Mendez-David I, David DJ, Darcet F, Wu MV, Kerdine-Romer S, Gardier AM, and others. 2014. Rapid anxiolytic effects of a 5-HT(4) receptor agonist are mediated by a neurogenesis-independent mechanism. Neuropsychopharmacology 39 (6): 1366-78.
87. Middlemiss DN, Price GW, Watson JM,. 2002. Serotonergic targets in depression. Curr Opin Pharmacol 2 (1): 18-22.
88. Ming GL, Song H,. 2005. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28: 223-50.
89. Mnie-Filali O, Pineyro G,. 2012. Desensitization and internalization mechanisms of the 5-HT4 receptors. Wiley Interdisciplin Rev Membrane Transp Signal 1 (6): 779-88.
90. Mori M, Murata Y, Matsuo A, Tomoyo T, Mine K,. 2014. Chronic treatment with the 5-HT1A receptor partial agonist tandospirone increases hippocampal neurogenesis. Neurol Ther 3 (1): 67-77.
91. Nestler EJ, Gould E, Manji H, Buncan M, Duman RS, Greshenfeld HK, and others. 2002. Preclinical models: status of basic research in depression. Biol Psychiatry 52 (6): 503-28.
92. Nibuya M, Morinobu S, Duman RS,. 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (11): 7539-47.
93. Nibuya M, Nestler EJ, Duman RS,. 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16 (7): 2365-72.
94. Ohtsuki T, Ishiguro H, Detera-Wadleigh SD, Toyota T, Shimizu H, Yamada K, and others. 2002. Association between serotonin 4 receptor gene polymorphisms and bipolar disorder in Japanese case-control samples and the NIMH Genetics Initiative Bipolar Pedigrees. Mol Psychiatry 7 (9): 954-61.
95. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M,. 1998. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad Sci U S A 95 (18): 10734-9.
96. Parsey RV, Ogden RT, Miller JM, Tin A, Hesselgrave N, Goldstein E, and others. 2010. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry 68 (2): 170-8.
97. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ,. 2006a. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31 (8): 1745-9.
98. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, and others. 2006b. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59 (2): 106-13.
99. Pascual-Brazo J, Castro E, Diaz A, Valdizan EM, Pilar-Cuellar F, Vidal R, and others. 2012. Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT(4) receptor agonist RS67333. Int J Neuropsychopharmacol 15 (5): 631-43.
100. Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M,. 2002. Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Gαs- and Gαi/o-proteins. Mol Pharmacol 61 (1): 85-96.
101. Polter AM, Li X,. 2010. 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal 22 (10): 1406-12.
102. Radley JJ, Jacobs BL,. 2002. 5-HT1A receptor antagonist administration decreases cell proliferation in the dentate gyrus. Brain Res 955 (1-2): 264-7.
103. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, and others. 1998. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A 95 (24): 14476-81.
104. Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, and others. 2010. 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65 (1): 40-52.
105. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, and others. 2011. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 31 (16): 6008-18.
106. Ridder S, Chourbaji S, Hellweg R, Urani A, Zacher C, Schmid W, and others. 2005. Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions. J Neurosci 25 (26): 6243-50.
107. Rosel P, Arranz B, Urretavizcaya M, Oros M, San L, Navarro MA,. 2004. Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims. Neuropsychobiology 49 (4): 189-95.
108. Roychowdhury S, Haas H, Anderson EG,. 1994. 5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells. Neuropharmacology 33 (3-4): 551-7.
109. Sahay A, Drew MR, Hen R,. 2007. Dentate gyrus neurogenesis and depression. Prog Brain Res 163: 697-722.
110. Samuels BA, Hen R,. 2011. Neurogenesis and affective disorders. Eur J Neurosci 33 (6): 1152-9.
111. Samuels BA, Leonardo ED, Gadient R, Williams A, Zhou J, David DJ, and others. 2011. Modeling treatment-resistant depression. Neuropharmacology 61 (3): 408-13.
112. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, and others. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (5634): 805-9.
113. Sapolsky R,. 2000. It's not 'all in the genes'. The environment you grow up in is as important as your DNA in determining the person you ultimately become. Newsweek 135 (15): 68.
114. Schatzberg AF, Nemeroff CB,. 2009. The American Psychiatric Publishing textbook of psychopharmacology. Washington, DC: American Psychiatric Publishing.
115. Schmidt EF, Warner-Schmidt JL, Otopalik BG, Pickett SB, Greengard P, Heintz N,. 2012. Identification of the cortical neurons that mediate antidepressant responses. Cell 149 (5): 1152-63.
116. Schreiber R., Melon C., De Vry J,. (1998). The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology (Berl) 135, 383-391.
117. Silvestre JS, Fernandez AG, Palacios JM,. 1996. Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test. Eur J Pharmacol 309 (3): 219-22.
118. Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB, and others. 2013. Dynamics of hippocampal neurogenesis in adult humans. Cell 153 (6): 1219-27.
119. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G,. 1998. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18 (18): 7394-401.
120. Strobel A, Gutknecht L, Rothe C, Reif A, Mossner R, Zeng Y, and others. 2003. Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J Neural Transm 110 (12): 1445-53.
121. Surget A, Saxe M, Leman S, Ibarguen-Vargas Y, Chalon S, Griebel G, and others. 2008. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol Psychiatry 64 (4): 293-301.
122. Tamburella A, Micale V, Navarria A, Drago F,. 2009. Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats. Prog Neuropsychopharmacol Biol Psychiatry 33 (7): 1205-10.
123. Tanaka KF, Samuels BA, Hen R,. 2012. Serotonin receptor expression along the dorsal-ventral axis of mouse hippocampus. Philos Trans R Soc Lond B Biol Sci 367 (1601): 2395-401.
124. Torres GE, Chaput Y, Andrade R,. 1995. Cyclic AMP and protein kinase A mediate 5-hydroxytryptamine type 4 receptor regulation of calcium-activated potassium current in adult hippocampal neurons. Mol Pharmacol 47 (1): 191-7.
125. Tunnicliff G,. 1991. Molecular basis of buspirone's anxiolytic action. Pharmacol Toxicol 69 (3): 149-56.
126. Vidal R, Valdizan EM, Vilaro MT, Pazos A, Castro E,. 2010. Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats. Br J Pharmacol 161 (3): 695-706.
127. Vilaro MT, Cortes R, Gerald C, Branchek TA, Palacios JM, Mengod G,. 1996. Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridization histochemistry. Brain Res Mol Brain Res 43 (1-2): 356-60.
128. Vilaro MT, Cortes R, Mengod G,. 2005. Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol 484 (4): 418-39.
129. Vilaro MT, Domenech T, Palacios JM, Mengod G,. 2002. Cloning and characterization of a novel human 5-HT4 receptor variant that lacks the alternatively spliced carboxy terminal exon. RT-PCR distribution in human brain and periphery of multiple 5-HT4 receptor variants. Neuropharmacology 42 (1): 60-73.
130. Waeber C, Sebben M, Grossman C, Javoy-Agid F, Bockaert J, Dumuis A,. 1993. [3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. Neuroreport 4 (11): 1239-42.
131. Waeber C, Sebben M, Nieoullon A, Bockaert J, Dumuis A,. 1994. Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33 (3-4): 527-41.
132. Wang JW, David DJ, Monckton JE, Battaglia F, Hen R,. 2008. Chronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cells. J Neurosci 28 (6): 1374-84.
133. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR,. 2007. The STAR∗D Project results: a comprehensive review of findings. Curr Psychiatry Rep 9 (6): 449-59.
134. Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P, and others. 2009. Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 29 (6): 1937-46.
135. World Health Organization. 2011. World health statistics 2011. Geneva, Switzerland: World Health Organization.